NASDAQ: MGRX - Mangoceuticals, Inc.

Yield per half year: -55.56%
Dividend yield: 0.00%
Sector: Healthcare

Mangoceuticals, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.77 -100% -2.58 -100%
P/S 8.81 33.77 -73.9%
P/BV 8.32 4.83 72.36%
P/FCF -3.06 61 -105.01%
Ev/Ebitda -0.6349 -22.17 -97.14%
Ev/S 7.98 22.57 -64.65%
Ev/FCF -0.8337 68.76 -101.21%
E/P -0.4305 0.0178 -2522.12%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-1256.88 4.97 -25378.84% -11746.24 -89.3%
ROE -1189.08 9.61 -12471.29%
ROA -876.71 0.3443 -254765.76%
ROIC 0 7.63 -100%
ROS -1259.4 -25.17 4903.55%
ROCE -1189.91 15.45 -7801.93%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.014 -3.68 -99.62% -0.4922 -97.16%
Nеt Debt/Ebitda 0.0664 -3.44 -101.93%
Debt/Ratio 0.1225 0.1986 -38.33%
Debt/Equity 0.1851 1.66 -88.86%
Debt/Net Income -0.014 10.32 -100.14%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.541 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2256 -100%
Average dividend growth 0 0.9598 -100%
Average percentage for 5 years 0 0.4928 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.541

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
8083.16 -57.64 -14123.53%
Growth impulse Ebitda in 5 years 50941.82 -90.94 -56116.96%
Growth impulse Net Income in 5 years 51080.09 -97.8 -52329.13%
Growth impulse FCF in 5 years 38793.86 -108.72 -35782.36%
Growth impulse EPS in 5 years 645042.6 -142.05 -454195.46%
IP Score
4.78/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription